Biomet has witnessed a strong end to fiscal 2010 after sales of its hip and knee products helped the firm record a 10% revenue growth and narrow its net loss for the fourth quarter. The orthopaedic specialist recorded Q4 revenue of $702.5m. The firm’s reconstructive business ...
Please Login to read the full article.
